Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA023077-06
Application #
4690964
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Takaue, Y; Watanabe, T; Kawano, Y et al. (1991) A simplified and rapid limiting dilution assay of T lymphocytes. Cell Immunol 133:526-31
Barlogie, B; Gahrton, G (1991) Bone marrow transplantation in multiple myeloma. Bone Marrow Transplant 7:71-9
Yau, J C; Reading, C L; Thomas, M W et al. (1990) Purging of T-lymphocytes with magnetic affinity colloid. Exp Hematol 18:219-22
Takaue, Y; Kawano, Y; Reading, C L et al. (1990) Effects of recombinant human G-CSF, GM-CSF, IL-3, and IL-1 alpha on the growth of purified human peripheral blood progenitors. Blood 76:330-5
Dunphy, F R; Spitzer, G; Buzdar, A U et al. (1990) Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. J Clin Oncol 8:1207-16
Jagannath, S; Barlogie, B; Dicke, K et al. (1990) Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors. Blood 76:1860-6
Barlogie, B; Epstein, J (1990) Multiple myeloma: biology and therapy. J Cancer Res Clin Oncol 116:109-11
Barlogie, B; Alexanian, R (1989) Prognostic factors in multiple myeloma: the M.D. Anderson experience. Eur J Haematol Suppl 51:84-7
Jagannath, S; Armitage, J O; Dicke, K A et al. (1989) Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol 7:179-85
Horwitz, L J; Kantarjian, H M; Jagannath, S et al. (1989) Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in advanced phases of chronic myelogenous leukemia. Bone Marrow Transplant 4:101-5

Showing the most recent 10 out of 48 publications